Tagged with R

Association of International Pharmaceutical Manufactures (AIPM) When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite similar to yours: he had been an administrator and head of the regulatory authority; he subsequently left the administration and…

American Chamber of Commerce in Russia The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief overview of the history of the Chamber? As the U.S.S.R. unraveled in 1991, a group of American businessmen informally created…

Association of Clinical Trials Organizations (ACTO) The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you give us an overview of the current clinical trial environment in Russia, and explain why a unified organization like ACTO…

Mackay Memoral Hospital Cheng-Ho Tsai, Mackay Memorial Hospital has a unique background and origins. How has this endured through the different stages of the pharmaceutical sector in Taiwan, and how do you see the continuity of it? Indeed, our institution is 130 years old. Our medical centre, which is one of the largest…

Astellas Pharma India Pvt. Ltd. When Astellas announced to expand its presence in India in 2009, you were already speaking of the company’s long commitment and solid relationship with India. Can you elaborate on these historical ties and how important it was to set up your India operations at that time? Since the former Fujisawa…

Nucleus Network Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research business, and is somewhat unique, as it is a not for profit organization, being wholly-owned by the Baker IDI Heart and Diabetes research institute. Originally, Nucleus Network was set…

Theraskin Brazil When we met you in 2007, as the head of the former Igefarma, the company was undergoing a transition – from branded generics into dermocosmetics and women’s health. But since that period of transition, there has been quite a transition again! Could you bring our readers up to speed? Since…

Generic Medicines Industry Association To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry organization. Its six members are: Alphapharm, Apotex, Genepharm, Hospira, Sandoz and Sigma. The GMiA is the lobby group for the generic medicines industry in Australia, working with all relevant stakeholders, such as government, prescribers,…

Allergan How have PBS reforms impacted Allergan in Australia? The PBS is a very good system that provides Australians with equity of access and has worked well in the country for many years. Once a therapeutic is approved and funded, Australia has one of the highest penetration rates around the world.…

Alphapharm Alphapharm recently celebrated its 25th anniversary. In light of this significant milestone, would you give us a brief introduction to the company? Alphapharm started in 1982 in Brisbane with a handful of products and a handful of people. Twenty-five years later, we celebrated our silver anniversary, coming from nowhere to…

Sanofi Australia What impact have the PBS reforms had on sanofi-aventis in Australia? Sanofi-aventis has one of the largest portfolios of medicines in Australia, with over 240 products in the key areas of cardiometabolic disease, thrombosis, oncology, vaccines, CNS, and internal medicine. The PBS reforms clearly are the major reforms over the…

Pretium Australia Would you please introduce Pretium’s specific service offerings, and the focus within these? Pretium offers a comprehensive range of integrated services across our 4 lines of business – Market Intelligence, Health Economics, Late Phase Research and Disease Management. The distinction between the various stages of a product’s life cycle and…